Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › EPAC1 activators as HIV latency reversal agents (LRA)

EPAC1 activators as HIV latency reversal agents (LRA)

US Patent 10633363 · Granted Apr 28, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for controlling battery power interface converter with ultra-wideband EIS2025
Borohydride reduction stabilizing system and method for reducing ester to alcoho2025
Bogie framework of rail vehicle and bogie2025
Compounds and methods for treating cancer2025
Marine cable multifunctional integrated software development platform, method, a2024
Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(2024
Fendiline derivatives2024
Bimetallic coordination metal-organic framework material, preparing method there2024
Retractable badge and key holder2023
Retractable badge and key holder2023
Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists2023
Compounds and methods for inhibiting viral replication and methods of treating a2023